INTRODUCTION: Few reports in the world have shown a differential effect of hypothyroidism in relation to morbidity and mortality following cardiac surgery. OBJECTIVE: To determine the association between preoperative hypothyroidism, composite and disaggregated outcomes of mortality and complications in patients undergoing first-time isolated myocardial revascularization surgery. METHODS: Historical cohort of patients undergoing myocardial revascularization between January 2008 and December 2014, with 626 patients included for evaluation of the composite and disaggregated outcomes of in-hospital mortality and complications (atrial fibrillation, surgical site infection and reoperation due to bleeding). A logistic regression model was used to determine the association between hypothyroidism and the onset of those outcomes. RESULTS: Cohort of 1696 eligible patients for the study, with 1.8 mortality. Median age, female gender and prevalence of arterial hypertension were all significantly higher among hypothyroid patients. No differences were found in other preoperative or intraoperative characteristics. Hypothyroidism was associated with the presence of the composite outcome, RR 1.6 (1.04-2.4) and atrial fibrillation 1.9 (1.05-3.8). No association with mortality, infections or reoperation due to bleeding was found. CONCLUSION: Hypothyroidism is a disease that affects females predominantly and does not determine the presence of other comorbidities. Hypothyroidism is a risk factor for the onset of postoperative fibrillation in patients undergoing myocardial revascularization surgery. Postoperative care protocols focused on the prevention of these complications in this type of patients must be instituted.
INTRODUCTION: Few reports in the world have shown a differential effect of hypothyroidism in relation to morbidity and mortality following cardiac surgery. OBJECTIVE: To determine the association between preoperative hypothyroidism, composite and disaggregated outcomes of mortality and complications in patients undergoing first-time isolated myocardial revascularization surgery. METHODS: Historical cohort of patients undergoing myocardial revascularization between January 2008 and December 2014, with 626 patients included for evaluation of the composite and disaggregated outcomes of in-hospital mortality and complications (atrial fibrillation, surgical site infection and reoperation due to bleeding). A logistic regression model was used to determine the association between hypothyroidism and the onset of those outcomes. RESULTS: Cohort of 1696 eligible patients for the study, with 1.8 mortality. Median age, female gender and prevalence of arterial hypertension were all significantly higher among hypothyroidpatients. No differences were found in other preoperative or intraoperative characteristics. Hypothyroidism was associated with the presence of the composite outcome, RR 1.6 (1.04-2.4) and atrial fibrillation 1.9 (1.05-3.8). No association with mortality, infections or reoperation due to bleeding was found. CONCLUSION:Hypothyroidism is a disease that affects females predominantly and does not determine the presence of other comorbidities. Hypothyroidism is a risk factor for the onset of postoperative fibrillation in patients undergoing myocardial revascularization surgery. Postoperative care protocols focused on the prevention of these complications in this type of patients must be instituted.
Authors: Damien J LaPar; Giovanni Filardo; Ivan K Crosby; Alan M Speir; Jeffrey B Rich; Irving L Kron; Gorav Ailawadi Journal: J Thorac Cardiovasc Surg Date: 2014-07-24 Impact factor: 5.209
Authors: Akshat Saxena; Diem Dinh; Julian A Smith; Gilbert Shardey; Christopher M Reid; Andrew E Newcomb Journal: Eur J Cardiothorac Surg Date: 2011-11-11 Impact factor: 4.191
Authors: Connie M Rhee; Steven Kim; Daniel L Gillen; Tolga Oztan; Jiaxi Wang; Rajnish Mehrotra; Sooraj Kuttykrishnan; Danh V Nguyen; Steven M Brunelli; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh Journal: J Clin Endocrinol Metab Date: 2015-01-29 Impact factor: 5.958
Authors: Ajay K Sharma; Eszter Vegh; Mary Orencole; Alexandra Miller; Dan Blendea; Stephanie Moore; Gregory D Lewis; Jagmeet P Singh; Kimberly A Parks; E Kevin Heist Journal: Am J Cardiol Date: 2015-02-12 Impact factor: 2.778
Authors: Young Joo Park; Ji Won Yoon; Kwang Il Kim; You Jin Lee; Kyung Won Kim; Sung Hee Choi; Soo Lim; Dong Ju Choi; Kay-Hyun Park; Joong Haeng Choh; Hak Chul Jang; Seong Yeon Kim; Bo Youn Cho; Cheong Lim Journal: Ann Thorac Surg Date: 2009-06 Impact factor: 4.330
Authors: Marco Vacante; Antonio Biondi; Francesco Basile; Roberto Ciuni; Salvatore Luca; Salomone Di Saverio; Carola Buscemi; Enzo Saretto Dante Vicari; Antonio Maria Borzì Journal: Front Endocrinol (Lausanne) Date: 2019-04-24 Impact factor: 5.555
Authors: Martin Aguilar; Robert A Rose; Abhijit Takawale; Stanley Nattel; Svetlana Reilly Journal: Cardiovasc Res Date: 2021-06-16 Impact factor: 10.787